Novel monoclonal antibody inhibits tumor growth in breast cancer and angiosarcoma
Friday, April 19, 2013 - 14:31
in Health & Medicine
A monoclonal antibody targeting a protein known as SFPR2 has been shown to inhibit tumor growth in pre-clinical models of breast cancer and angiosarcoma.